TY - JOUR
T1 - Autoimmune Pancreatitis
AU - Nagpal, Sajan Jiv Singh
AU - Sharma, Ayush
AU - Chari, Suresh T.
N1 - Publisher Copyright:
© 2018, American College of Gastroenterology.
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Over the course of the last 2 decades our knowledge of autoimmune pancreatitis has increased exponentially. In this review, we summarize the clinical presentation, diagnosis and treatment of AIP, to better allow general gastroenterologists and primary care providers to consider AIP as a as a rare but important cause of painless obstructive jaundice and recurrent acute pancreatitis. While steroids remain the mainstay of first line therapy, a number of patients with type 1 AIP require immunomodulators or rituximab to maintain remission; recommendations on the management of relapses continue to evolve.
AB - Over the course of the last 2 decades our knowledge of autoimmune pancreatitis has increased exponentially. In this review, we summarize the clinical presentation, diagnosis and treatment of AIP, to better allow general gastroenterologists and primary care providers to consider AIP as a as a rare but important cause of painless obstructive jaundice and recurrent acute pancreatitis. While steroids remain the mainstay of first line therapy, a number of patients with type 1 AIP require immunomodulators or rituximab to maintain remission; recommendations on the management of relapses continue to evolve.
UR - http://www.scopus.com/inward/record.url?scp=85048601563&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048601563&partnerID=8YFLogxK
U2 - 10.1038/s41395-018-0146-0
DO - 10.1038/s41395-018-0146-0
M3 - Review article
C2 - 29910463
AN - SCOPUS:85048601563
SN - 0002-9270
VL - 113
SP - 1301
EP - 1309
JO - American Journal of Gastroenterology
JF - American Journal of Gastroenterology
IS - 9
ER -